跳至主要内容
临床试验/IRCT2017032633143N1
IRCT2017032633143N1招募中2 期

Evalute and compare the effectiveness of oral thalidomide + Bortezomib (subcutaneous) + Dexamethasone(IV) regimen with Bortezomib (subcutaneous) + oral prednisolone + oral thalidomide regimen in patients with newly diagnosed multiple myeloma

Personal0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
30